The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 6, 2013, Pages 557-565

  Cosson, E ^a,b   Nguyen, M T ^a,b   Chanu, B ^a   Balta, S ^a   Takbou, K ^a   Valensi, P ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b INSERM   (France)

Author keywords

ALFEDIAM; American Diabetes Association; Cardiac radionuclide imaging guidelines; Diabetes; French Society of Cardiology; Guidelines; Retinopathy; Silent myocardial ischemia

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; DIABETIC RETINOPATHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

AGED; ASYMPTOMATIC DISEASES; BODY MASS INDEX; CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84878896546     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.01.009     Document Type: Article

References (30)

1. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998; 21: 1551-1559.
2. Puel J., Valensi P., Vanzetto G., Lassmann-Vague V., Monin J.L., Moulin P., et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004, 30. 3S3-18.
3. Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M.J., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
4. Bax J.J., Young L.H., Frye R.L., Bonow R.O., Steinberg H.O., Barrett E.J. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007, 30:2729-2736.
5. Hernandez C., Candell-Riera J., Ciudin A., Francisco G., Aguade-Bruix S., Simo R. Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovasc Diabetol 2011, 10:9.
6. Cosson E., Attali J.R., Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful?. Diabetes Metab 2005, 31:205-213.
7. Cosson E., Guimfack M., Paries J., Paycha F., Attali J.R., Valensi P. Prognosis for coronary stenoses in patients with diabetes and silent myocardial ischemia. Diabetes Care 2003, 26:1313-1314.
8. Cosson E., Nguyen M.T., Chanu B., Banu I., Chiheb S., Balta C., et al. Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients. Diabetes Care 2011.
9. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D.A., Davey J.A., Barrett E.J., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004, 27:1954-1961.
10. Cosson E., Guimfack M., Paries J., Paycha F., Attali J.R., Valensi P. Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?. Diabetes Metab 2003, 29:470-476.
11. Valensi P., Paries J., Brulport-Cerisier V., Torremocha F., Sachs R.N., Vanzetto G., et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 2005, 28:2722-2727.
12. Bansal S., Wackers F.J., Inzucchi S.E., Chyun D.A., Davey J.A., Staib L.H., et al. Five-Year outcomes in "High-Risk" participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. A Post-Hoc Analysis Diabetes Care 2011, 204-209.
13. Hendel R.C., Berman D.S., Di Carli M.F., Heidenreich P.A., Henkin R.E., Pellikka P.A., et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of cardiology Foundation appropriate use criteria task force, The American Society of Nuclear cardiology, The American College of Radiology, The American heart association, The American Society of Echocardiography, The Society of cardiovascular computed tomography, The Society for cardiovascular Magnetic Resonance, and The Society of Nuclear Medicine. J Am Coll Cardiol 2009, 53:2201-2229.
14. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
15. Klein R., Sharrett A.R., Klein B.E., Moss S.E., Folsom A.R., Wong T.Y., et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 2002, 109:1225-1234.
16. Janand-Delenne B., Savin B., Habib G., Bory M., Vague P., Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999, 22:1396-1400.
17. Ciccone M.M., Niccoli-Asabella A., Scicchitano P., Gesualdo M., Notaristefano A., Chieppa D., et al. Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease. Vasc Health Risk Manag 2011, 7:129-134.
18. Rajagopalan N., Miller T.D., Hodge D.O., Frye R.L., Gibbons R.J. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005, 45:43-49.
19. Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 2006, 47:65-71.
20. Hiebel A., Fagot-Campagna A., Fosse S., Varroud-Vial M., Weill A., Penfornis A. Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM-SFC 2004 Guidelines in a population of diabetic patients. Diabetes Metab 2010, 36:286-292.
21. Araz M., Celen Z., Akdemir I., Okan V. Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control. Acta Diabetol 2004, 41:38-43.
22. Gokcel A., Aydin M., Yalcin F., Yapar A.F., Ertorer M.E., Ozsahin A.K., et al. Silent coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol 2003, 40:176-180.
23. Nitenberg A., Valensi P., Sachs R., Cosson E., Attali J.R., Antony I. Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care 2004, 27:208-215.
24. Valensi P., Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab 2009, 36:91-96.
25. Young L.H., Wackers F.J., Chyun D.A., Davey J.A., Barrett E.J., Taillefer R., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. Jama 2009, 301:1547-1555.
26. Lievre M.M., Moulin P., Thivolet C., Rodier M., Rigalleau V., Penfornis A., et al. Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening. Trials 2011, 12:23.
27. Frye R.L., August P., Brooks M.M., Hardison R.M., Kelsey S.F., MacGregor J.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515.
28. Naka M., Hiramatsu K., Aizawa T., Momose A., Yoshizawa K., Shigematsu S., et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992, 123:46-53.
29. Valensi P., Sachs R.N., Lormeau B., Taupin J.M., Ouzan J., Blasco A., et al. Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 1997, 23:409-416.
30. Piot C., Fontbonne A., Sultan A., Rasamisoa M., Mariano-Goulart D., Davy J.M., et al. Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia. Diabetes Care 2003, 26:545-546.